Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03976219 · ClinicalTrials.gov registry record · NA
Measuring Evoked Potentials From the Spinal Cord and Dorsal Root Ganglion
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03976219: Clinical Trial NA study, sponsored by Duke University.
NCT03976219 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03976219, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of recording evoked compound action potentials (ECAPs) and somatosensory evoked potentials (SSEPs) from the spinal cord (SC) and Dorsal root ganglions (DRG), and their suitability as feedback signals.
Primary Outcome
Measured on a scale 0 to 10, with 0 being no pain and 10 being pain as bad as you can imagine.
Interventions
- OTHER ECAPS Closed Loop SCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-06-13 |
| Est. Completion | 2021-12-09 |
| Phase | NA |
Why NCT03976219 stopped before completion
NCT03976219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which ECAPS Closed Loop SCS is the first listed.
NCT03976219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03976219 about?
NCT03976219 is a clinical study titled "Measuring Evoked Potentials From the Spinal Cord and Dorsal Root Ganglion". The purpose of this study is to determine the feasibility of recording evoked compound action potentials (ECAPs) and somatosensory evoked potentials (SSEPs) from the spinal cord (SC) and Dorsal root ganglions (DRG), and their suitability as feedback signals.
What is the current status of trial NCT03976219?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-06-13. Estimated completion is 2021-12-09.
What interventions are being tested in trial NCT03976219?
The interventions under investigation include: ECAPS Closed Loop SCS (OTHER).
Who is sponsoring clinical trial NCT03976219?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03976219's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI